Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmacological Mechanism of Ketamine in Suicidal Behavior Based on Animal Models of Aggressiveness and Impulsivity: A Narrative Review.

Autor: Nguyen, Thi Mai Loan¹ (AUTHOR), Jollant, Fabrice^2,3,4,5 (AUTHOR), Tritschler, Laurent¹ (AUTHOR), Colle, Romain^2,3 (AUTHOR), Corruble, Emmanuelle^2,3 (AUTHOR), Gardier, Alain M.¹ (AUTHOR) alain.gardier@universite-paris-saclay.fr

Publikováno v: Pharmaceuticals (14248247). Apr2023, Vol. 16 Issue 4, p634. 21p.

Peer effects on worker output in the laboratory generalize to the field.

Autor: Herbst, Daniel¹, Mas, Alexandre^1,2,3 amas@princeton.edu

Publikováno v: Science. 10/30/2015, Vol. 350 Issue 6260, p545-549. 5p.

Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics.

Autor: Seeman, P.^1,2 philip.seeman@utoronto.ca, Ko, F.¹, Tallerico, T.²

Publikováno v: Molecular Psychiatry. Sep2005, Vol. 10 Issue 9, p877-883. 7p.

Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability.

Autor: Bonaventura J; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA. jordi.bonaventura@nih.gov., Lam S; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Carlton M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Boehm MA; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Gomez JL; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Solís O; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Sánchez-Soto M; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke Intramural Research Program, Bethesda, MD, USA., Morris PJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, Rockville, MD, USA., Fredriksson I; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Thomas CJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, Rockville, MD, USA., Sibley DR; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke Intramural Research Program, Bethesda, MD, USA., Shaham Y; Neurobiology of Relapse Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA., Zarate CA Jr; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, Intramural Research Program, Bethesda, MD, USA., Michaelides M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA. mike.michaelides@nih.gov.; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. mike.michaelides@nih.gov.

Publikováno v: Molecular psychiatry [Mol Psychiatry] 2021 Nov; Vol. 26 (11), pp. 6704-6722. Date of Electronic Publication: 2021 Apr 15.